Sysmex to Launch HISCL Presepsin Assay Kit for Sepsis Testing

Publisher: The Insight Partners

Sysmex Corporation announced the launch of its HISCL Presepsin Assay Kit, which can be used with its Automated Immunoassay System HISCL-5000/2000i/800 for immunochemistry testing (HISCL-Series). This is a reagent for measuring levels of presepsin, a major test parameter for bacterial sepsis.

Sysmex Corp. is engaged in the development, manufacturing, import, export, and sales of clinical laboratory instruments, reagents, as well as software used in in-vitro diagnostic applications. The company also offers clinical laboratory testing for blood, urine, and other specimens. Sysmex Corporation’s products include instruments and reagent diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through reporting geographical segments that includes Japan, Americas, EMEA, China, and Asia Pacific. The company was founded on February 20, 1968 and is headquartered in Kobe, Japan.

The company considers reinforcing corporate governance as of one of its most vital management topics. Sysmex has a global network of operations throughout the world with export operations in more than 90 countries. The prime target customers of Sysmex includes public and national hospitals, universities, private hospitals and clinics, research & medical institutes and others.